Enzo

Enzo Biochem Q3 Revenues Nearly Double on Clinical Lab Testing Demand

FDA Grants EUA to Enzo Biochem Sample Collection Kit for COVID-19 Testing

Enzo Biochem Q2 Revenues Up 62 Percent

Enzo Biochem Sees a Path for Growth Beyond COVID Testing

Enzo Biochem Q1 Revenues Up 42 Percent

In Brief This Week: Enzo Biochem, 4D Path, Proscia, Quest Diagnostics, and More

Enzo Biochem Q4 Revenues Down 7 Percent

Enzo Biochem, CPESN NY to Provide COVID-19 Testing at 52 Pharmacies in New York State

FDA Grants EUAs for Enzo Life Sciences, Access Bio, Gene By Gene Coronavirus Tests

In Brief This Week: Centogene, Humana, Enzo Biochem, Todos Medical, and More

Enzo Biochem Q3 Revenues Down 14 Percent

In Brief This Week: BioReference Laboratories, Sophia Genetics, Enzo Biochem, and More

Commercial Labs Step up Coronavirus Test Efforts After FDA Guidance

Enzo Biochem Q2 Revenues Tick Up Less Than 1 Percent

New York State Approves Enzo Biochem STI Tests on GenFlex Platform

Enzo Biochem Fiscal Q1 Revenues Down 5 Percent

In Brief This Week: Inspirata, PerkinElmer, Foundation Medicine, and More

Enzo Biochem Fiscal Q4 Revenues Down 8 Percent

Enzo Clinical Labs Gets NY State Approval for HBV Assay

Federal Appeals Court Invalidates Second Enzo Biochem Patent in Three Months